ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 411,19
-0,75%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Prothena Corporation PLC (PRTA)

  7. Prothena Corporation PLC (PRTA) Actualités

PRTA Prothena Corporation PLC

22,93
0,89 (4,04%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Prothena Corporation PLC PRTA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,89 4,04% 22,93 06:00:02
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
22,99 22,74 23,70 22,93 22,04
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202422:05BWProthena to Report First Quarter 2024 Financial Results on..
15/4/202422:05BWProthena Announces Review on Birtamimab Mechanism of Action..
06/3/202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202403:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/3/202422:05BWProthena to Participate in Upcoming Healthcare Conferences
04/3/202422:05BWProthena Appoints David Ford to Newly Created Chief People..
01/3/202403:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202403:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202403:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202403:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202423:29EDGAR2Form S-3ASR - Automatic shelf registration statement of..
22/2/202422:56EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/2/202422:06EDGAR2Form 8-K - Current report
21/2/202422:05BWProthena Announces Appointment of Daniel G. Welch as..
15/2/202422:09EDGAR2Form 8-K - Current report
15/2/202422:05BWProthena Reports Fourth Quarter and Full Year 2023 Financial..
14/2/202418:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202401:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:05BWProthena to Report Fourth Quarter and Full Year 2023..
25/1/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:06EDGAR2Form 144 - Report of proposed sale of securities
08/1/202414:35EDGAR2Form 8-K - Current report
08/1/202414:30BWProthena Provides Updates on PRX012, PRX123, Birtamimab and..
21/12/202301:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:03EDGAR2Form 144 - Report of proposed sale of securities
01/12/202300:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202322:05EDGAR2Form 144 - Report of proposed sale of securities
02/11/202321:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:09EDGAR2Form 8-K - Current report
02/11/202321:05BWProthena Reports Third Quarter 2023 Financial Results and..
26/10/202322:05BWProthena to Report Third Quarter 2023 Financial Results on..
26/10/202302:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202322:01EDGAR2Form 144 - Report of proposed sale of securities
12/10/202302:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202322:02EDGAR2Form 144 - Report of proposed sale of securities
05/10/202301:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:03EDGAR2Form 144 - Report of proposed sale of securities
28/9/202302:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202322:01EDGAR2Form 144 - Report of proposed sale of securities
25/9/202322:56EDGAR2Form 144 - Report of proposed sale of securities
19/9/202323:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202322:51EDGAR2Form 144 - Report of proposed sale of securities
14/9/202301:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202301:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202322:33EDGAR2Form 144 - Report of proposed sale of securities
13/9/202322:01EDGAR2Form 144 - Report of proposed sale of securities
07/9/202301:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
PRTA
Prothena
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés